Market closedNon-fractional
Solventum Corporation/SOLV
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Solventum Corporation
Solventum Corp is an independent healthcare company with a primary focus on addressing healthcare challenges. Its diverse product portfolio spans the healthcare industry, including medical solutions, oral care, health information systems, and separation and purification sciences.
Ticker
SOLV
Sector
Healthcare
Trading on
NYSE
Industry
Health Care Equipment and Supplies
Headquarters
Saint Paul, United States
Employees
22,000
Website
www.solventum.com
SOLV Metrics
BasicAdvanced
$9.9B
Market cap
7.71
P/E ratio
$7.46
EPS
-
Beta
-
Dividend rate
Price and volume
Market cap
$9.9B
Financial strength
Current ratio
1.812
Quick ratio
1.195
Long term debt to equity
215.606
Total debt to equity
215.606
Interest coverage (TTM)
43.69%
Management effectiveness
Return on equity (TTM)
16.55%
Valuation
Price to earnings (TTM)
7.71
Price to revenue (TTM)
1.212
Price to book
2.58
Price to tangible book (TTM)
-1.83
Price to free cash flow (TTM)
6.534
Growth
Revenue change (TTM)
1.47%
Earnings per share change (TTM)
0.27%
What the Analysts think about SOLV
Analyst Ratings
Majority rating from 4 analysts.
SOLV Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$2B
-0.98%
Net income
$237M
-12.87%
Profit margin
11.75%
-11.99%
SOLV Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q1 24
Q2 24
Actual
$2.08
-
Expected
$1.75
$1.50
Surprise
19.20%
-
SOLV News
AllArticlesVideos
Nelson Peltz's Trian said to build stake in 3M spinoff Solventum, Bloomberg News reports
Reuters·4 days ago
Solventum Stock Jumps as Activist Trian Discloses Stake
Barrons·4 days ago
Solventum to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024
PRNewsWire·2 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Solventum Corporation stock?
Solventum Corporation (SOLV) has a market cap of $9.9B as of July 27, 2024.
What is the P/E ratio for Solventum Corporation stock?
The price to earnings (P/E) ratio for Solventum Corporation (SOLV) stock is 7.71 as of July 27, 2024.
Does Solventum Corporation stock pay dividends?
No, Solventum Corporation (SOLV) stock does not pay dividends to its shareholders as of July 27, 2024.
When is the next Solventum Corporation dividend payment date?
Solventum Corporation (SOLV) stock does not pay dividends to its shareholders.
What is the beta indicator for Solventum Corporation?
Solventum Corporation (SOLV) does not currently have a Beta indicator.
Buy or sell Solventum Corporation stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.